Media Coverage

While Lyme disease once was thought to be as reliably of New England as lockjaw and lobster rolls, the tick-borne ailment that hits both young children and older adults especially hard is now officially everywhere, at least according to a new study from lab giant Quest Diagnostics.

Participants in the BFOR study sign up for genetic testing at no cost by logging on to the website (www.BFORStudy.com) and answering a series of questions to determine eligibility. Educational videos explain the specifics of the test, the purpose of genetic testing and its importance. In all, the registration process takes no more than an hour. The site also allows patients to schedule genetic-testing appointments at the offices of Quest Diagnostics, which has several locations in each of the four cities. They can opt to have results sent to a personal physician or a health-care provider on the BFOR study team.

A new study by Quest Diagnostics has ranked Georgia third in the nation for the most increases in Lyme disease between 2015 and 2017.

here's been a sharp spike in Lyme disease cases in the United States, and the tick-borne illness has now spread to all 50 states, a new report shows. "Lyme disease is a bigger risk to more people in the United States than ever before," said Dr. Harvey Kaufman, senior medical director for Quest Diagnostics, which conducted the study.

Blockchain is here to stay. Here is what we need to do to make it better.

Last month’s Alzheimer’s Association International Conference (AAIC) 2018 heralded many announcements, including the mixed reception around Phase II trials results from Biogen’s Alzheimer’s drug BAN2401. Like many treatments in AD, it addressed build up of amyloid plaques in the brain. However, many drug failures in that area, as well as Pfizer’s exodus from Alzheimer’s and Parkinson’s research early this year, has led to investors and scientists to reevaluate the plaque theory. Edward I. Ginns, MD, PhD, medical director, neurology, for Quest Diagnostics, said, “When we see patients at the point of clinical identification, the brain is pretty much out of resources. It’s unlikely that neurons that are dead or non-functional will be treated at that late stage.” To that end, Quest Diagnostics wanted to identify patients with cognition problems earlier. They developed CogniSense, a cognition test that is available as an app for the iPad and given in the primary care doctor’s office.

Opioid use—and abuse—among construction workers has become the industry’s silent crisis. It frequently begins with pain, typically from jobsite-related injuries, including falls, or from tasks involving repetitive motion. Excessive exposure to vibration—in addition to bending, twisting and awkward postures—inflicts particularly hard wear and tear on backs, knees, shoulders and other joints.

llinois workers in retail, health care and administrative services and waste management were most likely to fail a drug test in 2017, according to data from a national testing company. [CR-LF]Quest Diagnostics, headquartered in Secaucus, N.J., tested more than 10 million urine samples nationally for marijuana, opiates, cocaine and other drugs. About 5 percent of Illinois retail workers tested positive for drugs, followed by 4.8 percent of workers in health care and social assistance, and 4.3 percent in administrative services and waste management.